STONKWHISPER
← Back to Intel
Insider ActivityETON

Krempa David, Chief Business Officer at Eton Pharmaceuticals, Inc., sold $316K of ETON

Updated Jun 21, 2026
Krempa David Chief Business Officer
Eton Pharmaceuticals, Inc. · $ETON
$316K Total Value
9,315 Shares Traded
$33.8802 Price / Share
25,768 Shares Owned After
2026-05-27 Filing Date

Transaction Details

InsiderKrempa David
TitleChief Business Officer
CompanyEton Pharmaceuticals, Inc.
TickerETON
Transaction TypeSale
Transaction Date2026-05-22
Shares Traded9,315
Price Per Share$33.8802
Total Value$316K
Filed Date2026-05-27
Accession Number0001437749-26-018628

Ownership Context

Shares Owned After Transaction25,768
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001437749-26-018628

Other Insider Trades — ETON

Other Trades by Krempa David

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ETON — Eton Pharmaceuticals, Inc. →

Track ETON insider activity in real time on The Wire →

Get alerts when Krempa David files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 21, 2026 at 07:10 UTC

Want real-time data? Access The Wire for live sentiment tracking.